Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened, West-African women over 35 years of age

International Journal of Cancer

Volumn 103, Issue 6, 2003, Pages 803-809

  Xi, Long Fu ^a   Touré, Papa ^c   Critchlow, Cathy W ^b   Hawes, Stephen E ^b   Dembele, Birama ^c   Sow, Papa Salif ^c   Kiviat, Nancy B ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

Author keywords

Africa; Human papillomavirus; Squamous intraepithelial lesion

Indexed keywords

ADULT; AFRICA; ARTICLE; CANCER CYTODIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INVASION; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROPREVALENCE; SQUAMOUS CELL; SQUAMOUS EPITHELIUM; UTERINE CERVIX CARCINOMA IN SITU; VACCINATION; VERRUCA VULGARIS; VIRUS STRAIN; WART VIRUS;

ADULT; AGE DISTRIBUTION; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; SENEGAL; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0037348555     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10876     Document Type: Article

References (45)

1. IARC. Monographs on the evaluation of the carcinogenic risks to humans. Human papillomaviruses. vol 64. Lyon: IARC, 1995.
2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
3. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, Scott DR, Sherman ME, Kurman RJ, Wacholder S, Stanton CK, Manos MM. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithetial neoplasia. J Natl Cancer Inst 1993;85:958-64.
4. Herrington CS. Human papillomaviruses and cervical neoplasia. I. Classification, virology, pathology and epidemiology. J Clin Pathol 1994;47:1066-72.
5. Cox JT. Epidemiology of cervical intraepithelial neoplasia: the role of human papillomavirus. Baillieres Clin Obstet Gynaecol 1995;9:1-37.
6. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
7. Peyton CL, Gravitt PE, Hunt WC, Hundley RS, Zhao M, Apple RJ, Wheeler CM. Determinants of genital human papillomavirus detection in a US population. I Infect Dis 2001;183:1554-64.
8. Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, Meijer CJ. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 2000;87:221-7.
9. Cuzick J, Beverley E, Ho L, Terry G, Sapper H, Mielzynska I, Lorincz A, Chan WK, Krausz T, Soutter P. HPV testing in primary screening of older women. Br J Cancer 1999;81:554-8.
10. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Plummer M, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000;92:464-74.
11. Lazcano-Ponce E, Herrero R, Munoz N, Cruz A, Shah KV, Alonso P, Hernandez P, Salmeron J, Hernandez M. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001;91:412-20.
12. Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Desy M, Rohan TE. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999;180:1415-23.
13. Huang S, Afonina I, Miller BA, Beckmann AM. Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer 1997;70:408-11.
14. Liaw KL, Hsing AW, Schiffman MH, You SL, Zhang T, Burk R, Chen CJ. Human papillomavirus types 52 and 58 are prevalent in cervical cancer from Chinese women. Int J Cancer 1997;73:775-6.
15. Lin QQ, Yu SZ, Qu W, Cruz Y, Burk RD. Human papillomavirus types 52 and 58. Int J Cancer 1998;75:484-5.
16. Chan PK, Li WH, Chan MY, Ma WL, Cheung JL, Cheng AF. High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions. J Med Virol 1999;59:232-8.
17. Chabaud M, Le Cann P, Mayelo V, Leboulleux D, Diallo AS, Enogat N, Afoutou JM, Anthonioz P, Coll-Seck AM, Coursaget P. Detection by PCR of human papillomavirus genotypes in cervical lesions of Senegalese women. J Med Virol 1996;49:259-63.
18. Engels H, Nyongo A, Temmerman M, Quint WG, Van Marck E, Eylenbosch WJ. Cervical cancer screening and detection of genital HPV-infection and chlamydial infection by PCR in different groups of Kenyan women. Ann Soc Belg Med Trop 1992:72:53-62.
19. ter Meulen J, Eberhardt HC, Luande J, Mgaya HN, Chang-Claude J, Mtiro H, Mhina M, Kashaija P, Ockert S, Yu X, Meinhardt G, Gissmann L, et al. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, East Africa. Int J Cancer 1992;51:515-21.
20. Castellsague X, Menendez C, Loscertales MP, Kornegay JR, dos Santos F, Gomez-Olive FX, Lloveras B, Abarca N, Vaz N, Barreto A, Bosch FX, Alonso P. Human papillomavirus genotypes in rural Mozambique. Lancet 2001;358:1429-30.
21. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999;49:33-64.
22. The 1988 Bethesda system for reporting cervical/vaginal cytological diagnoses. National Cancer Institute Workshop. JAMA 1989;262: 931-4.
23. Kuypers JM, Critchlow CW, Gravitt PE, Vernon DA, Sayer JB, Manos MM, Kiviat NB. Comparison of dot filter hybridization. Southern transfer hybridization and polymerase chain reaction amplification for diagnosis of anal human papillomavirus infection. J Clin Microbiol 1993;31:1003-6.
24. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998;36:3020-7.
25. Ananth CV, Kleinbaum DG. Regression models for ordinal responses: a review of methods and applications. Int J Epidemiol. 1997;26:1323-33.
26. Womack SD, Chirenje ZM, Gaffikin L, Blumenthal PD, McGrath JA, Chipato T, Ngwalle S, Munjoma M, Shah KV. HPV-based cervical cancer screening in a population at high risk for HIV infection. Int J Cancer 2000;85:206-10.
27. La Ruche G, You B, Mensah-Ado I, Bergeron C, Montcho C, Ramon R, Toure-Coulibaly K, Welffens-Ekra C, Dabis F, Orth G. Human papiliomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women. Int J Cancer 1998;18:480-6.
28. Kreiss JK, Kiviat NB, Plummer FA, Roberts PL, Waiyaki P, Ngugi E, Holmes KK. Human immunodeficiency virus, human papillomavirus and cervical intraepithelial neoplasia in Nairobi prostitutes. Sex Transm Dis 1992;19:54-9.
29. de Roda Husman AM, Walboomers JM, Hopman E, Bleker OP, Helmerhorst TM, Rozendaal L, Voorhorst FJ, Meijer CJ. HPV prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by PCR: the age-related pattern. J Med Virol 1995;46:97-102.
30. Melkert PW, Hopman E, van den Brule AJ. Risse EK, van Diest PJ, Bleker OP, Helmerhorst T, Schipper ME, Meijer CJ, Walboomers JM. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age dependent. Int J Cancer 1993;53:919-23.
31. Sasagawa T, Basha W, Yamazaki H, Inoue M. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol Biomarker Prev 2001;10: 45-52.
32. Chan PK, Chang AR, Cheung JL, Chan DP, Xu LY, Tang NL, Cheng AF. Determinants of cervical human papillomavirus infection: differences between high-and low-oncogenic risk types. J Infect Dis 2002; 185:28-35.
33. Giuliano AR, Papenfuss M, Abrahamsen M, Denman C, de Zapien JG, Henze JL, Ortega L, Brown de Galaz EM, Stephan J, Feng J, Baldwin S, Garcia F, et al. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control. Cancer Epidemiol Biomarkers Prev 2001;10:1129-36.
34. Matsukura T, Sugase M. Cloning of a novel human papillomavirus (type58) from an invasive cervical carcinoma. Virology 1990;177: 833-6.
35. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, Peyton CL, Bauer HM, Wheeler CM. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence and phylogenetic algorithms. J Infect Dis 1994;170: 1077-85.
36. Kirii Y, Iwamoto S, Matsukura T. Human papillomavirus type 58 DNA sequence. Virology 1991;185:424-7.
37. Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, Darragh TM, Brescia R, Kanowitz S, Miller SB, Stone J, Hanson E, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998;132:277-84.
38. Liaw KL, Glass AG, Manos MM, Greer CE, Scott DR, Sherman M, Burk RD, Kurman RJ, Wacholder S, Rush BB, Cadell DM, Lawler P, et al. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst 1999;91:954-60.
39. Schiff M, Becker TM, Masuk M, van Asselt-King L, Wheeler CM, Altobelli KK, North CQ, Nahmias AJ. Risk factors for cervical intraepithelial neoplasia in Southwestern American Indian women. Am J Epidemiol 2000;152:716-26.
40. Castellsague X, Menendez C, Loscertales MP, Kornegay JR, dos Santos F, Gomez-Olive FX, Lloveras B, Abarca N, Vaz N, Barreto A, Bosch FX, Alonso P. Human papillomavirus genotypes in rural Mozambique. Lancet 2001;358:1429-30.
41. Apple RJ, Erlich HA, Klitz W, Manos MM, Becker TM, Wheeler CM. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet 1994;6:157-62.
42. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;12:423-8.
43. Liaw KL, Hsing AW, Chen CJ, Schiffman MH, Zhang TY, Hsieh CY, Greer CE, You SL, Huang TW, Wu TC, O'Leary TJ, Seidman JD, et al. Human papillomavirus and cervical neoplasia: a case-control study in Taiwan. Int J Cancer 1995;4:565-71.
44. Ho GY, Kadish AS, Burk RD, Basu J, Palan PR, Mikhail M, Romney SL. HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia. Int J Cancer 1998;29:281-5.
45. Gravitt PE. Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38:357-61.